The study aimed to screen potential key genes, and their targeted miRNAs and transcription factors (TFs) that were related to diffuse large B-cell lymphoma (DLBCL), and explore potential therapeutic targets for the progression of DLBCL. Dataset GSE56315 extracted from human tonsils was downloaded from Gene Expression Omnibus. Limma package was used to identify differential expression genes (DEG) between DLBCL and normal human tonsils samples, and the function and pathway enrichment analyses were performed. Then, functional interaction (FI) networks analyses of DEGs were implemented, and modules were extracted. Additionally, DLBCL-related miRNAs were predicted based on miR2disease database. Thereafter, TF-target DEGs and miRNAs targeted genes were respectively obtained. Finally, the integrated network of TF-target-miRNA was constructed. A total of 4,495 DEGs were identified between DLBCL and NHT samples. Among them, 114 up-regulated DEGs were contained in 8 modules of FI network, while 189 down-regulated DEGs were contained in 12 sub-modules. In addition, most DEGs were enriched in the function of "DNA binding" and pathways of "chemokine signaling pathway", "phosphatidylinositol signaling system" and "RNA degradation". Moreover, 19 miRNAs related with DLBCL were downloaded from Mirwalk2. Furthermore, miRNAs of miR-21-5p, miR-155 and miR-17-5p, the TF of STAT1, and DEGs such as NUF2, CCR1, PIK3R1, SMC1A, FOXK1 and CNOT6L had high degrees in the integrated networks of TF-target-miRNA. DEGs like NUF2, CCR1, PIK3R1, SMC1A, FOXK1 and CNOT6L might be closely associated with the pathogenesis of DLBCL.
Diffuse large B-cell lymphoma (DLBCL), a heterogeneous group of malignant proliferation of mature B cells, is one common kind of Non-Hodgkin's lymphoma (NHL) and accounts for 30% of NHL [1, 2] . In addition, DLBCL can be classified into two subgroups, germinal center B cell-like (GCB) and activated B cell-like (ABC) subgroups, based on the cDNA microarrays [3] . The incidence rate of DLBCL is about 10-15 of 100,000 people annually in the United States and most of them are men [4] . Additionally, inflammatory response is an important action in the development of DLBCL, and other genetic and environmental factors may also contribute to the acceleration of lymphomagenesis in DLBCL. Current treatment of DLBCL is typically combined chemotherapy. However, the relapse rate of DLBCL patients is nearly 40% [5] . Therefore, it is necessary to further develop new methods after comprehensive understanding pathogenic mechanisms of DLBCL from molecular level.
At present, the DLBCL related gene markers and molecular basis are partially understood. Several gene markers have been reported to be associated with the development of DLBCL. For instance, V-Myc avian myelocytomatosis viral oncogene homolog (MYC) is overexpressed in patients with DLBCL and contributes to tumorigenesis via repression of miR-17-92 cluster expression [6] . In addition, the down-regulated expression of miR-34a which increases its targets of p53, forkhead box p1 (FOXP1) and b-cell CLL/lymphoma 2 (BCL2), serves as a crucial prognostic marker of DLBCL in daily clinical work [7] . Similarly, Banham et al have found that the high expression of FOXP1 transcription factor (TF) may be closely linked with pathogenesis of DLBCL [8] . Furthermore, B lymphocyte-induced maturation protein 1 (BLIMP1), as a tumor suppressor gene, is inactivated by deletions or mutation in patients with DLBCL, and the inactivation of BLIMP1 lead to lymphomagenesis by obstruction B cells differentiation [9] .
Moreover, some pathways have been recently identified to be associated with the lymphomagenesis of DLBCL. The activation of nuclear factor kappa B (NF-κB) pathway is a hallmark of the ABC subtype of DLBCL, and may result in a change of the tumor cell proliferation and survival of DLBCL [10, 11] .
Despite these informative findings, the gene and molecular mechanism involved in DLBCL is still obscure, and it needs to be further elucidated, which contributes to the clinical therapy and diagnosis of DLBCL. A previous study by Dybkaer et al hypothesizes to provide new diagnostic and prognostic tests for DLBCL based on subset-specific B-cell-associated gene signatures (BAGS) [12] , and they have demonstrated that CD58, LMO2, several histocompatibility complex class II-signature and stromal-1-signature genes that may have a positive influence on prognosis of BAGS-assigned centrocyte subtype. However, they failed to comprehensively use those BAGS data to screen the key genes of DLBCL. In the present study, we reanalyzed their expression profile via a series of bioinformatics methods and the purpose of this study was to identify the key DLBCL related gene targets for providing important reference of further therapy and diagnosis of DLBCL.
Materials and methods
Data resource. All the data used in this study were downloaded from Gene Expression Omnibus (GEO, https://www. ncbi.nlm.nih.gov/geo/) website with the accession number of GSE56315 [12] , which based on the platform of Affymetrix Human Genome U133 Plus 2.0 Array. A total of 122 samples were consisted in this profile, including 89 DLBCL samples and 33 normal human tonsils (NHT) samples.
Data preprocessing. Firstly, the raw probel-level data in CEL format were downloaded. Then, preprocessing of expression profile data were conducted by using Affy package in R language, such as format transformation of raw data, missing data filling, background correction by MAS method and normalization using quartile method [13] .
Differentially expressed genes (DEGs) analysis and hierarchical clustering. Following the data preprocessing, the DEGs between DLBCL and NHT samples were analyzed by non-paired t test implemented in Linear Models for Microarray Analysis (limma, http://www.bioconductor.org/packages/ release/bioc/html/limma.html) package in R [14] , and multiple testing adjustment were performed by Benjamini & Hochberg method to adjust the original P-value into the false discovery rate (FDR) [15] . The FDR < 0.01 and |log2 fold change (FC)| ≥ 2 were chosen as the cut-off criteria to filter DEGs. Then, the pheatmap package in R (http://cran.r-project.org/web/ packages/pheatmap/index.html) was used to perform clustering analysis [16] .
Function and pathway enrichment analyses of DEGs. The Multifaceted Analysis Tool for Human Transcriptome (MATHT, http://www.biocloudservice.com) is an online tool for Gene Ontology (GO) function [17] , and Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/ kegg/) pathway analyses [18] . In this study, the MATHT tool was used to perform GO and KEGG enrichment analyses for the up-regulated and down-regulated DEGs, respectively, both with the cut-off criterion of P < 0.05.
Gene functional interaction (FI) analysis. The Reac-tomeFIViz is a Cytoscape app that allows further network analysis based on Reactome gene pathway annotations, and the networks were divided into modules with the Reactome-FIViz built-in "cluster FI network" tool [19] . In addition, ReactomeFIViz can calculate the pearson correlation coefficient (PCC) of each module. Then, modules were obtained with the parameter of MCLclustering size = 10. Moreover, the Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov) was used to perform pathway enrichment analysis for each module gene set [20] .
The integrated network construction of TF-target-miRNA. At first, the miRNAs related to DLBCL were searched from miR2disease (http://www.mir2disease.org/) database, and the validated target genes of 19 DLBCL-related miRNAs were downloaded from Mirwalk2 [21] . Then, these target genes and up-regulated or down-regulated DEGs were overlapped, respectively, using Venn diagram analysis, to select potential miRNA-DEG interactions. The iRegulon plugin (http://iregulon.aertslab.org.) in Cytoscape is aimed to detect enriched TF motifs and their optimal sets of direct targets [22] . In our study, iRegulon plugin was used to search the TFs of the miRNAtargeted genes based on the following parameters: minimum identity between orthologous genes: 0.05; maximum FDR on motif similarity: 0.001. The output result was Normalized Enrichment Score (NES), and the higher the score was, the more reliable of the prediction. The TF-target interactions with NES > 4 were selected, and then these targets were overlapped with DEGs, to identify the TFs of DEGs. Finally, the predicted TF-target-miRNA networks were constructed for up-regulated and down-regulated DEGs, respectively, by using Cytoscape software (http://www.cytoscape.org/) [23] .
Results

DEGs screening and hierarchy cluster analysis.
Based on the aforementioned criteria, a total of 4,495 DEGs were identified between DLBCL samples and NHT samples, including 2,224 up-regulated genes and 2,271 down-regulated genes in DLBCL samples. Additionally, the hierarchy cluster analysis revealed that the DEGs could correctly differentiate the two kinds of samples with correlated expression profiles, indicating that the DEGs could be applied to further analysis (Figure 1 ).
Function and pathway enrichment analyses of DEGs. Using the MATHT online tool, enrichment analyses indicated that the up-regulated DEGs were significantly related to functions such as "immune response", "ribosome", "chemotaxis" and "taxis", and pathways such as "chemokine signaling pathway" (e.g., CCR1) and "cytokine-cytokine receptor interaction" (Figure 2 ). In addition, the down-regulated DEGs were signifi cantly related to functions such as "non-membrane-bounded organelle" and "DNA binding'' (e.g., FOXK1), and pathways such as "ribosome" and "spliceosome" (Figure 3 , Table 1 ).
Gene FI network of DEGs. As a result, a total of 8 modules of the FI network were obtained for the up-regulated DEGs ( Figure 4A ), including 114 nodes corresponding with 357 interactions. In those modules, the top 3 important modules were purple module with 24 DEGs (average PCC = 0.7801), green module with 18 DEGs (average PCC = 0.7362) and rose red module with 17 DEGs (average PCC = 0.8412). While, a total of 12 modules were obtained for the down-regulated DEGs, including 189 nodes corresponding with 1391 interactions ( Figure 4B ). Among those down-regulated modules, the top 3 important modules were respectively purple module with 39 DEGs (average PCC = 0.8211), green module with 24 DEGs (average PCC = 0.8532) and rose red module with 17 DEGs (average PCC = 0.8762) ( Table 2) .
Pathway enrichment analysis of the module gene sets. Based on the DAVID database, only gene sets from 10 modules were enriched in corresponding KEGG pathways, among which 5 modules were from up-regulated DEGs and 5 modules were from down-regulated DEGs. As a result, up-regulated DEGs were remarkably enriched in pathways such as "cell cycle" (e.g., ESPL1) and "phosphatidylinositol signaling system" ( e.g., PIK3R1). Meanwhile, down-regulated DEGs were closely associated with pathway of "RNA degradation" (e.g., CNOT6L) ( Table 3) .
Th e integrated TF-target-miRNA network. In the integrated TF-target-miRNA network of the up-regulated DEGs, Regulation of actin cytoskeleton 6 3.32E-02 CDC42, ARHGEF7, RAC1, ARHGEF12, FGD3… Notes: Count stands for the number of differentially expressed genes which were enriched in the corresponding functional category. only one TF, STAT1, was found to have relationships with miRNA-targeted DEGs, such as NUF2, CCR1 and DTX3L ( Figure 5 ). PIK3R1 was another crucial node in this network with high degree. By contrast, no TF was searched for the down-regulated DEGs, and DEGs such as SMC1A, FOXK1 and CNOT6L were highlighted with high connection degrees were integrated in the down-regulation network ( Figure 6 ). Additionally, two miRNAs,hsa-miR-21-5p (degree = 10) and hsa-miR-17-5p (degree = 25), which related to DLBCL had high connection degrees in above two TF-target-miRNA networks. Moreover, ten DEGs (e.g., CCR1, PIK3R1 and SMC1A) were identified to be the targets of hsa-miR-21-5p, whilst twenty five DEGs such as FOXK1 and CNOT6L were targets of hsa-miR-17-5p.
Discussion
In the present study, a total of 114 up-regulated and 189 down-regulated DEGs were identified. Eight modules of the FI network were constructed for the up-regulated DEGs, while 12 were for the down-regulated DEGs. In addition, DEGs such as NUF2, CCR1, PIK3R1, SMC1A, FOXK1 and CNOT6L, the miRNAs of hsa-miR-21-5p, miR-155 and hsa-miR-17-5p, and the TF of STAT1 were highlighted in the TF-target-miRNA networks. Moreover, most DEGs were predicted to be related to the function of "DNA binding'' (e.g., FOXK1) and pathways like "phosphatidylinositol signaling system" (e.g., PIK3R1), "chemokine signaling pathway" (e.g., CCR1) and pathway of "RNA degradation" (e.g., CNOT6L). Signal transducer and activator of transcription 1 (STAT1) belongs to the STAT family, which is activated by tyrosine phosphorylation and crucial to develop human neoplasias via participating in the regulation of cell proliferation and survival [24] . Previous studies have showed that STAT1 plays an important role in promoting apoptosis [25] . In the present study, the STAT1 was the only TF in the TF-target-miRNA network for up-regulated DEGs, and was predicted to regulate the expression of NUF2, suggesting it might have an inhibitory role in DLBCL development. In addition, it is indicated that NDC80 kinetochore complex component (NUF2) was up-regulated in human glioma cells and pancreatic tissues, and NUF2 plays an important role in regulation cell apoptosis [26, 27] . Th erefore, it could be inferred that the overexpression of STAT1 might induce the up-regulation of NUF2. Th ese regulations might contribute to inhibit the progression of DLBCL via promoting cell apoptosis. However, there are some diff erent views on the role of STAT1 in DLBCL. Bhatt et al have demonstrated that interleukin 21 can induce cell apoptosis in a subset of mantle cell lymphoma cells via activating the STAT3-cMyc pathway and not by activating the STAT1 signaling pathway [29] . In addition, Camicia et al have suggested that BAL1 as a oncogenic survival factor in DLBCL may induce the phosphorylation of STAT1, and STAT1 acts as an oncogene in DLBCL, not as tumor suppressor [30] . Th erefore, it is still needed further experimental data to verify the function of STAT1 in DLBCL.
Numerous studies have proved that miR-21 has great function in the development of DLBCL and other cancers via regulating cell proliferation and apoptosis [31] [32] [33] . In our study, CCR1, PIK3R1 and SMC1A were predicted as target genes of miR-21-5p, and CCR1 and PIK3R1 had high degrees in the up-regulated network of TF-target-miRNA. Th e chemokine receptor 1 (CCR1) encodes a member of the beta chemokine receptor family, and it can bind to C-X-C motif chemokine to have function in the progression of tumors [34] . Interestingly, a previous study indicated that the expression of CCR1 was up-regulated in the non-germinal center subtype of DLBCL, and CCR1 may contribute to the progression of DLBCL via chemokine signaling pathway [35] , which was consistent with our fi ndings. In addition, phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) is negatively regulated by miR-21-5p, and miR-21-5p targeted PIK3R1 inhibits cell growth and invasion via suppressing PI3K/AKT signaling activation in breast cancer [36] . Moreover, PI3K/AKT pathway is involved in the development of DLBCL [37] . Similarly, chemokine signaling pathway and PI3K/AKT signaling pathway were predicted to be signifi cant pathways in this study. Th erefore, it might be supposed that CCR1 and PIK3R1 might function as important genes to participate the development of DLBLC via those two pathways. Structural maintenance of chromosomes 1A (SMC1A) that encodes a subunit of the cohesin protein complex is involved in chromosome cohesion during cell cycle and DNA repair [38] . On the other hand, in the present study, SMC1A showed high degree in the down-regulated network. The knockdown of SMC1A suppresses the growth of glioblastoma cells [38, 39] . Collectively, we supposed that miR-21, as well as its target genes like CCR1, PIK3R1 and SMC1A might control the growth of DLBCL cells. Additionally, it has been indicated that miR-155 overexpression plays important roles in the progression of DLBCL [40] . In our study, SMAD4 as the target gene of miR-155 was predicted to be down-regulated in the DLBCL cells. In consistent with our result, Go et al have found that the loss of SMAD4 expression may be related with the proliferation of DLBCL cells by enhancing transforming growth factor β (TGF-β) pathway signaling pathway [41] . In addition, it has been reported that miR-155 may regulate SMAD4 in TGF-β1/SMAD signaling pathway in human breast cancer cells [42] . Therefore, we supposed that miR-155 and its target gene SMAD4 might play key role in the occurrence of lymphoma of DLBCL via TGF-β1 pathway.
Moreover, several studies have proved that miR-17-5p plays a role as a tumor suppressor in malignant cells such as breast cancer cell, lung cancer cell and gastric cancer cell [43] [44] [45] . In our study, FOXK1 and CNOT6L, which were two crucial genes with a high connection degree in the integrated network of down-regulated genes, were predicted as the targeted genes of miR-17-5p. Myocyte nuclear factor (FOXK1) contains a fork head DNA binding domain which is correlative with cell growth and metabolism, and FOXK1 suppression lead to apoptosis and promote cell susceptibility to 5-fluorouracilinduced apoptosis in colorectal cancer cell [46] . In addition, CCR4-NOT transcription complex subunit 6 like (CNOT6L) is a deadenylase subunit of CCR4-NOT complex [47] . Moreover, CNOT6L is linked to cell death and survival by recognizing the RNA substrate and causing mRNA degradation [48] . Furthermore, miR-17 can bind to CNOT6L to down-regulate the level of phosphatase and tensin homolog (PTEN), and thus to facilitate tumor growth [49] . In consistent with our results, FOXK1 and CNOT6L were enriched in the pathways of "DNA binding'' and "RNA degradation", respectively. Consequently, we inferred that FOXK1 and CNOT6L which participated in "DNA binding'' and "RNA degradation" are most likely to play a major role in the progression of DLBCL via regulation of cell growth and apoptosis of DLBCL cells by targeting miR-17.
In summary, the DEGs like NUF2, CCR1, PIK3R1, SMC1A, SMAD4, FOXK1 and CNOT6L, the TF of STAT1, and the miRNAs such as miR-21-5p, miR-155 and miR-17-5p might be closely involved in the progression of DLBCL via regulation the cell proliferation and apoptosis. Moreover, they might be used as potential therapeutic and diagnostic biomarkers for DLBCL. However, further studies should be designed to confirm these results.
